GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36349
Submission : 2022-07-04
Status : Active
Type : IV

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
FINISHED DOSAGE FORMULATIONS
SORBITAN TRIOLEATE
Route : INHALATION
CAS : 26266-58-0
UNII : QE6F49RPJ1
Potency Amount : 0.069
Potency Unit : %

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SORBITAN TRIOLEATE
Route : INHALATION
CAS : 26266-58-0
UNII : QE6F49RPJ1
Potency Amount : 0.86
Potency Unit : %

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SORBITAN TRIOLEATE
Route : NASAL
CAS : 26266-58-0
UNII : QE6F49RPJ1
Potency Amount : 0.018
Potency Unit : %

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SORBITAN TRIOLEATE
Route : ORAL
CAS : 26266-58-0
UNII : QE6F49RPJ1
Potency Amount : 0
Potency Unit : NA

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SORBITAN TRIOLEATE
Route : ORAL
CAS : 26266-58-0
UNII : QE6F49RPJ1
Potency Amount : 0
Potency Unit : NA

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SORBITAN TRIOLEATE
Route : ORAL
CAS : 26266-58-0
UNII : QE6F49RPJ1
Potency Amount : 1.5
Potency Unit : MG/5ML

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SORBITAN TRIOLEATE
Route : ORAL
CAS : 26266-58-0
UNII : QE6F49RPJ1
Potency Amount : 0
Potency Unit : NA

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SORBITAN TRIOLEATE
Route : ORAL
CAS : 26266-58-0
UNII : QE6F49RPJ1
Potency Amount : 0
Potency Unit : NA

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SORBITAN TRIOLEATE
Route : ORAL
CAS : 26266-58-0
UNII : QE6F49RPJ1
Potency Amount : 0
Potency Unit : NA

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
EXCIPIENTS BY APPLICATIONS